We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.80
Bid: 55.80
Ask: 56.80
Change: 0.30 (0.54%)
Spread: 1.00 (1.792%)
Open: 55.00
High: 56.80
Low: 55.00
Prev. Close: 56.00
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of finance for Purchase of Land

2 Aug 2018 07:00

RNS Number : 5552W
Accsys Technologies PLC
02 August 2018
 

 

 

2 August 2018 AIM: AXS

Euronext Amsterdam: AXS

 

ACCSYS TECHNOLOGIES PLC

("Accsys" or "the Company") 

Completion of Purchase of Arnhem Land and Buildings

Accsys, the fast growing and sustainable chemical technology group, today announces that is has completed the purchase of the land and buildings associated with its Accoya® plant and logistics centre in Arnhem, the Netherlands.

The purchase, from its landlord Bruil for €23m, was announced on 1 May 2018, subject to finance. It has been financed with a partially amortising five year package comprising €19m from ABN AMRO and a commercial loan of €4m.

The financing terms will result in a lower overall income statement charge over the next 20 years. The acquisition also reflects Accsys's continued successful efforts to improve its overall financing arrangements.

 

Ownership of the land is expected to provide enhanced strategic options, operational security and greater flexibility in respect of the use of the land.

 

ACCSYS TECHNOLOGIES PLC ("Accsys" of "de Vennootschap")

 

Voltooiing van de aankoop van de grond en gebouwen in Arnhem

 

Accsys, de snelgroeiende chemische technologiegroep, maakt vandaag bekend dat de aankoop van de grond en gebouwen ten behoeve van de productie van Accoya® en het logistieke centrum in Arnhem succesvol is afgerond.

 

Op 1 mei 2018 werd de aankoop ter waarde van € 23 miljoen, onder voorbehoud van financiering, reeds aangekondigd. De verwerving is gefinancierd middels een lening ter grootte van € 19 miljoen van ABNAMRO die gedeeltelijk in vijf jaar zal worden afgelost en een commerciële lening ter grootte van € 4 miljoen.

 

De kosten van de aangetrokken financiering zullen resulteren in lagere lasten gedurende de 20-jarige looptijd van de financiering. Verder demonstreert deze transactie Accsys' continue succesvolle inzet om haar financieringsarrangementen te verbeteren.

 

Eigendom van de grond zal naar verwachting de strategische opties, bedrijfszekerheid en de flexibiliteit ten aanzien van het gebruik van de grond, verbeteren.

Ends

 

 

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

Hans Pauli, Executive Director, Corporate Development

via MHP Communications

Numis Securities

Nominated Adviser:

Jamie Lillywhite

Corporate Broking:

Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derkse

+31 681 734 236

+31 222 379 666

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a highly sustainable and environmentally responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of naturally occurring 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

Accsys Technologies is the trading name of Titan Wood Limited. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUAVWRWAAWRAR
Date   Source Headline
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTrading Update
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022
10th Jun 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.